-
EP2638044
European procedure
Extract from the Register of European Patents
EP Citations: EP2638044
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2004029055
[A] (BAYER HEALTHCARE AG [DE], et al) [A] 1-17* claim 1 *; | Type: | Patent literature | Publication No.: | WO2008070150
[ID] (BAYER PHARMACEUTICALS CORP [US], et al) [ID] 1-17 * page 80; example 11; claim 1 *; | Type: | Patent literature | Publication No.: | WO2010034414
[I] (BAYER SCHERING PHARMA AG [DE], et al) [I] 1-17 * page 21; example Ia; claim 1 * | Cited in | by applicant | Type: | Patent literature | Publication No.: | US5011472
| Type: | Patent literature | Publication No.: | US5023252
| Type: | Patent literature | Publication No.: | WO2008070150
| Type: | Non-patent literature | Publication information: | - PURE APPL CHEM, (1976), vol. 45, pages 11 - 30 | Type: | Non-patent literature | Publication information: | - S. M. BERGE ET AL., "Pharmaceutical Salts", J. PHARM. SCI., (1977), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560 | DOI: | http://dx.doi.org/10.1002/jps.2600660104 | Type: | Non-patent literature | Publication information: | - Organic Reactions, JOHN WILEY | Type: | Non-patent literature | Publication information: | - Organic Syntheses, JOHN WILEY | Type: | Non-patent literature | Publication information: | - Reagents for Organic Synthesis, JOHN WILEY | Type: | Non-patent literature | Publication information: | - The Total Synthesis of Natural Products, JOHN WILEY | Type: | Non-patent literature | Publication information: | - The Organic Chemistry of Drug Synthesis, JOHN WILEY | Type: | Non-patent literature | Publication information: | - Annual Reports in Organic Synthesis, ACADEMIC PRESS | Type: | Non-patent literature | Publication information: | - HOUBEN-WEYL, Methoden der Organischen Chemie, THIEME | Type: | Non-patent literature | Publication information: | - SCIFINDER, Handbuch der Organischen Chemie | Type: | Non-patent literature | Publication information: | - "The ACS Style Guide", Guidelines for Authors for the Journal of Organic Chemistry | Type: | Non-patent literature | Publication information: | - POWELL, M. F. ET AL., "Compendium of Excipients for Parenteral Formulations", PDA JOURNAL OF PHARMACEUTICAL SCIENCE & TECHNOLOGY, (1998), vol. 52, no. 5, pages 238 - 311, XP009119027 | Type: | Non-patent literature | Publication information: | - STRICKLEY, R.G, "Parenteral Formulations of Small Molecule Therapeutics Marketed in the United States", PDA JOURNAL OF PHARMACEUTICAL SCIENCE & TECHNOLOGY 1999, (1999), vol. 53, no. 6, pages 324 - 349 | Type: | Non-patent literature | Publication information: | - NEMA, S., "Excipients and Their Use in Injectable Products", PDA JOURNAL OF PHARMACEUTICAL SCIENCE | Type: | Non-patent literature | Publication information: | - GOODMAN, GILMAN'S, The Pharmacological Basis of Therapeutics, MCGRAW-HILL, (1996), pages 1225 - 1287 | Type: | Non-patent literature | Publication information: | - AIELLO ET AL., NEW ENGL. J. MED., (1994), vol. 331, page 1480 | Type: | Non-patent literature | Publication information: | - PEER ET AL., LAB. INVEST., (1995), vol. 72, page 638 | Type: | Non-patent literature | Publication information: | - LOPEZ ET AL., INVEST. OPTHTHALMOL. VIS. SCI., (1996), vol. 37, page 855 | Type: | Non-patent literature | Publication information: | - "Multiple signaling pathways converge on p-catenin in thyroid cancer", ABBOSH, P.H., NEPHEW, K.P., Thyroid, (2005), vol. 15, pages 551 - 561 | Type: | Non-patent literature | Publication information: | - AIELLO, L.P., AVERY, R.L., ARRIGG, P.G., KEYT, B.A., JAMPEL, H.D., SHAH, S.T., PASQUALE, L.R., THIEME, H., IWAMOTO, M.A., PARK, J., "Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders", N. ENGL. J. MED., (1994), vol. 331, doi:doi:10.1056/NEJM199412013312203, pages 1480 - 1487, XP002690192 | DOI: | http://dx.doi.org/10.1056/NEJM199412013312203 | Type: | Non-patent literature | Publication information: | - ALI, I.U., SCHRIML, L.M., DEAN, M. J., "Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity", NATL. CANCER LNST., (1999), vol. 91, pages 1922 - 1932 | Type: | Non-patent literature | Publication information: | - BACHMAN, K.E., ARGANI, P., SAMUELS, Y., SILLIMAN, N., PTAK, J., SZABO, S., KONISHI, H., KARAKAS, B., BLAIR, B.G., LIN, C., "The PIK3CA gene is mutated with high frequency in human breast cancers", CANCER BIOL. THERAP., (2004), vol. 3, doi:doi:10.4161/cbt.3.8.994, pages 772 - 775, XP055035716 | DOI: | http://dx.doi.org/10.4161/cbt.3.8.994 | Type: | Non-patent literature | Publication information: | - BADER, A.G., KANG, S.;, VOGT, P.K., "Cancer-specific mutations in PIK3CA are oncogenic in vivo", PROC. NATL. ACAD. SCI. U.S.A., (2006), vol. 103, doi:doi:10.1073/PNAS.0510857103, pages 1475 - 1479, XP002687647 | DOI: | http://dx.doi.org/10.1073/PNAS.0510857103 | Type: | Non-patent literature | Publication information: | - BARTHWAL, M.K., SATHYANARAYANA, P., KUNDU, C.N., RANA, B., PRADEEP, A., SHARMA, C., WOODGETT, J.R., RANA, A, "Negative Regulation of Mixed Lineage Kinase 3 by Protein Kinase B/AKT Leads to Cell Survival", J. BIOL. CHEM., (2003), vol. 278, pages 3897 - 3902 | Type: | Non-patent literature | Publication information: | - BÉNISTANT, C., CHAPUIS, H., ROCHE, S., "A specific function for phosphatidylinositol 3-kinase a (p85?-p110?) in cell survival and for phosphatidylinositol 3- kinase p (p85a-p110p) in de novo DNA synthesis of human colon carcinoma cells", ONCOGENE, (2000), vol. 19, doi:doi:10.1038/sj.onc.1203871, pages 5083 - 5090, XP002484274 | DOI: | http://dx.doi.org/10.1038/sj.onc.1203871 | Type: | Non-patent literature | Publication information: | - BISSERY, M.-C., NOHYNEK, G., SANDERINK, G.-J., LAVELLE, F., "Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: preclinical experience", ANTI-CANCER DRUGS, (1995), vol. 6, pages 339 - 355 | Type: | Non-patent literature | Publication information: | - BRODERICK, D.K., DI, C., PARRETT, T.J., SAMUELS, Y.R., CUMMINS, J.M., MCLENDON, R.E., FULTS, D.W., VELCULESCU, V.E., BIGNER, D.D.,, "Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas", CANCER RES., (2004), vol. 64, doi:doi:10.1158/0008-5472.CAN-04-1170, pages 5048 - 5050, XP002517093 | DOI: | http://dx.doi.org/10.1158/0008-5472.CAN-04-1170 | Type: | Non-patent literature | Publication information: | - BROWN, R.A., SHEPHERD, P.R., "Growth factor regulation of the novel class II phosphoinositide 3-kinases", BIOCHEM. SOC. TRANS., (2001), vol. 29, pages 535 - 537 | Type: | Non-patent literature | Publication information: | - BRUGGE, J., HUNG, M.-C., MILLS, G.B., "A new mutational aktivation in the P13K pathway", CANCER CELL, (2007), vol. 12, pages 104 - 107 | Type: | Non-patent literature | Publication information: | - BRUNET, A., BONNI, A., ZIGMOND, M.J., LIN, M.Z., JUO, P., HU, L.S., ANDERSON, M.J., ARDEN, K.C., BLENIS, J., GREENBERG, M.E, "Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor", CELL, (1999), vol. 96, doi:doi:10.1016/S0092-8674(00)80595-4, pages 857 - 868, XP002922384 | DOI: | http://dx.doi.org/10.1016/S0092-8674(00)80595-4 | Type: | Non-patent literature | Publication information: | - BYUN, D.-S., CHO, K., RYU, B.-K., LEE, M.-G., PARK, J.-I., CHAE, K.-S., KIM, H.-J., CHI, S.-G., "Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma", INT. J. CANCER, (2003), vol. 104, pages 318 - 327 | Type: | Non-patent literature | Publication information: | - CAMPBELL, I.G., RUSSELL, S.E., CHOONG, D.Y.H., MONTGOMERY, K.G., CIAVARELLA, M.L., HOOI, C.S.F., CRISTIANO, B.E., PEARSON, R.B., P, "Mutation of the PIK3CA gene in ovarian and breast cancer", CANCER RES., (2004), vol. 64, pages 7678 - 7681 | Type: | Non-patent literature | Publication information: | - CARDONE, M.H., ROY, N., STENNICKE, H.R., SALVESEN, G.S., FRANKE, T.F., STANBRIDGE, E., FRISCH, S., REED, J.C., "Regulation of cell death protease caspase-9 by phosphorylation", SCIENCE, (1998), vol. 282, pages 1318 - 1321 | Type: | Non-patent literature | Publication information: | - CHEN, Y.L., LAW, P.-Y., LOH, H.H., "Inhibition of P!3K/Akt signaling: An emerging paradigm for targeted cancer therapy", CURR. MED. CHEM.: ANTI-CANCER AGENTS, (2005), vol. 5, pages 575 - 589, XP009098139 | Type: | Non-patent literature | Publication information: | - CIECHOMSKA, I., PYRZYNSKA, B., KAZMIERCZAK, P., KAMINSKA, B., "Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for up- regulation of FasL expression in apoptosis of glioma cells", ONCOGENE, (2003), vol. 22, pages 7617 - 7627 | Type: | Non-patent literature | Publication information: | - CROSS, D.A.E., ALESSI, D.R, COHEN, P., ANDJELKOVICH, M., HEMMINGS, B.A., "Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B", NATURE, (1995), vol. 378, doi:doi:10.1038/378785a0, pages 785 - 789, XP002025954 | DOI: | http://dx.doi.org/10.1038/378785a0 | Type: | Non-patent literature | Publication information: | - CULLY, M., YOU, H., LEVINE, A.J., MAK, T.W., "Beyond PTEN mutations: the P13K pathway as an integrator of multiple inputs during tumorigenesis", NAT. REV. CANCER, (2006), vol. 6, pages 184 - 192 | Type: | Non-patent literature | Publication information: | - CZAUDERNA, F., FECHTNER, M., AYGUN, H., ARNOLD, W., KLIPPEL, A., GIESE, K., KAUFMANN, J., "Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA", NUCLEIC ACIDS RES., (2003), vol. 31, doi:doi:10.1093/nar/gkg141, pages 670 - 682, XP002992229 | DOI: | http://dx.doi.org/10.1093/nar/gkg141 | Type: | Non-patent literature | Publication information: | - DALY, C, WONG, V., BUROVA, E., WEI, Y., ZABSKI, S., GRIFFITHS, J., LAI, K.-M., LIN, H.C., LOFFE, E., YANCOPOULOS, G.D., "Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOX01", GENES DEV., (2004), vol. 18, pages 1060 - 1071 | Type: | Non-patent literature | Publication information: | - DEL PESO, L., GONZAIEZ-GARCIA, M., PAGE, C., HERRERA, R., NUNEZ, G., "Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt", SCIENCE, (1997), vol. 278, pages 687 - 689, XP002958941 | Type: | Non-patent literature | Publication information: | - DIEHL, J.A., CHENG, M., ROUSSEL, M.F.;, SHERR, C.J., "Glycogen synthase kinase-3b regulates cyclin D1 proteolysis and subcellular localization", GENES DEV., (1998), vol. 12, pages 3499 - 3511 | Type: | Non-patent literature | Publication information: | - DIJKERS, P.F., MEDEMA, R.H., LAMMERS, J.-W.J., KOENDERMAN, L., COFFER, P.J., "Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the Forkhead transcription factor FKHR-L1", CURR. BIOL., (2000), vol. 10, pages 1201 - 1204 | Type: | Non-patent literature | Publication information: | - DOMIN, J., WATERFIELD, M.D., "Using structure to define the function of phosphoinositide 3-kinase family members", FEBS LETT., (1997), vol. 410, doi:doi:10.1016/S0014-5793(97)00617-0, pages 91 - 95, XP004261759 | DOI: | http://dx.doi.org/10.1016/S0014-5793(97)00617-0 | Type: | Non-patent literature | Publication information: | - DOWNES, C.P., GRAY, A., LUCOCQ, J.M., "Probing phosphoinositide functions in signaling and membrane trafficking", TRENDS CELL BIOL., (2005), vol. 15, doi:doi:10.1016/j.tcb.2005.03.008, pages 259 - 268, XP004872259 | DOI: | http://dx.doi.org/10.1016/j.tcb.2005.03.008 | Type: | Non-patent literature | Publication information: | - EDELMAN, M.J., GANDARA, D.R., "Promising new agents in the treatment of non-small cell lung cancer", CANCER CHEMOTHERAP. PHARMACOL., (1996), vol. 37, pages 385 - 393 | Type: | Non-patent literature | Publication information: | - FIGUEROA, C., TARRAS, S., TAYLOR, J., VOJTEK, A.B., "Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex", J. BIOL. CHEM., (2003), vol. 278, doi:doi:10.1074/jbc.M307357200, pages 47922 - 47927, XP002996244 | DOI: | http://dx.doi.org/10.1074/jbc.M307357200 | Type: | Non-patent literature | Publication information: | - FLEMING, I.N., GRAY, A., DOWNES, C.P., "Regulation of the Rac1-specific exchange factor tiam1 involves both phosphoinositide 3-kinase-dependent and - independent components", BIOCHEM. J., (2000), vol. 351, pages 173 - 182 | Type: | Non-patent literature | Publication information: | - FUNAKI, M., KATAGIRI, H., INUKAI, K., KIKUCHI, M., ASANO, T., "Structure and function of phosphatidylinositol-3,4 kinase", CELL. SIGNALLING, (2000), vol. 12, pages 135 - 142 | Type: | Non-patent literature | Publication information: | - GALLIA, G.L., RAND, V., SIU, I.M., EBERHART, C.G., JAMES, C.D., MARIE, S.K.N., OBA-SHINJO, S.M., CARLOTTI, C.G., CABALLERO, O.L.,, "PIK3CA gene mutations in pediatric and adult glioblastoma multiforme", MOL. CANCER RES., (2006), vol. 4, pages 709 - 714 | Type: | Non-patent literature | Publication information: | - GARCIA-ROSTAN, G., COSTA, A.M., PEREIRA-CASTRO, I., SALVATORE, G., HERNANDEZ, R.;, HERMSEM, M.J.A., HERRERO, A., FUSCO, A., CAMESE, "Mutation of the PIK3CA gene in anaplastic thyroid cancer", CANCER RES., (2005), vol. 65, pages 10199 - 10207 | Type: | Non-patent literature | Publication information: | - GERSHTEIN, E.S., SHATSKAYA, V.A., ERMILOVA, V.D., KUSHLINSKY, N.E., KRASIL'NIKOV, M.A., "Phosphatidylinositol 3-kinase expression in human breast cancer", CLIN. CHIM. ACTA, (1999), vol. 287, pages 59 - 67 | Type: | Non-patent literature | Publication information: | - GOTTSCHALK, A.R., DOAN, A., NAKAMURA, J.L., STOKOE, D., HAAS-KOGAN, D.A, "Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism", INT. J. RADIAT. ONCOL. BIOL. PHYS., (2005), vol. 63, doi:doi:10.1016/j.ijrobp.2005.08.014, pages 1221 - 1227, XP025262460 | DOI: | http://dx.doi.org/10.1016/j.ijrobp.2005.08.014 | Type: | Non-patent literature | Publication information: | - GUPTA, A.K., CERNIGLIA, G.J., MICK, R., AHMED, M.S., BAKANAUSKAS, V.J., MUSCHEL, R.J., MCKENNA, W.G., "Radiation sensitization of human cancer cells in vivo by inhibiting the activity of P13K using LY294002", INT. J. RADIAT. ONCOL. BIOL. PHYS., (2003), vol. 56, doi:doi:10.1016/S0360-3016(03)00214-1, pages 846 - 853, XP002327025 | DOI: | http://dx.doi.org/10.1016/S0360-3016(03)00214-1 | Type: | Non-patent literature | Publication information: | - HAAS-KOGAN, D., SHALEV, N., WONG, M., MILLS, G., YOUNT, G., STOKOE, D., "Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC", CURR. BIOL., (1998), vol. 8, pages 1195 - 1198 | Type: | Non-patent literature | Publication information: | - HARTMANN, C., BARTELS, G., GEHLHAAR, C., HOLTKAMP, N., VON DEIMLING, A., "PIK3CA mutations in glioblastoma multiforme", ACTA NEUROPATHOL., (2005), vol. 109, doi:doi:10.1007/s00401-005-1000-1, pages 639 - 642, XP019340738 | DOI: | http://dx.doi.org/10.1007/s00401-005-1000-1 | Type: | Non-patent literature | Publication information: | - HENNESSY, B.T., SMITH, D.L., RAM, P.T., LU, Y., MILLS, G.B., "Exploiting the P!3K/AKT Pathway for Cancer Drug Discovery", NAT. REV. DRUG DISC., (2005), vol. 4, pages 988 - 1004 | Type: | Non-patent literature | Publication information: | - HODGKINSON, C.P., SALE, E.M., SALE, G.J., "Characterization of PDK2 activity against Protein Kinase B gamma", BIOCHEMISTRY, (2002), vol. 41, doi:doi:10.1021/bi026065r, pages 10351 - 10359, XP002409946 | DOI: | http://dx.doi.org/10.1021/bi026065r | Type: | Non-patent literature | Publication information: | - HRESKO, R.C., MURATA, H., MUECKLER, M., "Phosphoinositide-dependent Kinase-2 is a distinct protein kinase enriched in a novel cytoskeletal fraction associated with adipocyte plasma membranes", J. BIOL. CHEM., (2003), vol. 278, pages 21615 - 21622 | Type: | Non-patent literature | Publication information: | - HUANG, C., MA, W.-Y., DONG, Z., "Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells", MOL. CELL. BIOL., (1996), vol. 16, pages 6427 - 6435 | Type: | Non-patent literature | Publication information: | - HUPP, T.R., LANE, D.P.;, BALL, K.L., "Strategies for manipulating the p53 pathway in the treatment of human cancer", BIOCHEM. J., (2000), vol. 352, pages 1 - 17 | Type: | Non-patent literature | Publication information: | - LHLE, N.T., WILLIAMS, R., CHOW, S., CHEW, W., BERGGREN, M.I., PAINE-MURRIETA, G., MINION, D.J., HALTER, R.J., WIPF, P., ABRAHAM, R, "Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling", MOL. CANCER THER., (2004), vol. 3, pages 763 - 772, XP002532313 | Type: | Non-patent literature | Publication information: | - IKENOUE, T., KANAI, F., HIKIBA, Y., OBATA, T., TANAKA, Y., IMAMURA, J., OHTA, M., JAZAG, A., GULENG, B., TATEISHI, K., "Functional analysis of PIK3CA gene mutations in human colorectal cancer", CANCER RES., (2005), vol. 65, pages 4562 - 4567 | Type: | Non-patent literature | Publication information: | - ISHII, N., MAIER, D., MERLO, A., TADA, M., SAWAMURA, Y.;, DISERENS, A.-C., VAN MEIR, E.G., "Frequent co-alterations of TP53, p16/CDKN2A, pl4ARF, PTEN tumor suppressor genes in human glioma cell lines", BRAIN PATHOL., (1999), vol. 9, pages 469 - 479 | Type: | Non-patent literature | Publication information: | - ITOH, T., TAKENAWA, T., "Phosphoinositide-binding domains. Functional units for temporal and spatial regulation of intracellular signalling", CELL. SIGNALLING, (2002), vol. 14, pages 733 - 743 | Type: | Non-patent literature | Publication information: | - JANSSEN, J.W.G., SCHLEITHOFF, L., BARTRAM, C.R., SCHULZ, A.S., "An oncogenic fusion product of the phosphatidylinositol 3-kinase p85b subunit and HUMORF8, a putative deubiquitinating enzyme", ONCOGENE, (1998), vol. 16, pages 1767 - 1772 | Type: | Non-patent literature | Publication information: | - JIA, S., LIU, Z., ZHANG, S., LIU, P., ZHANG, L., LEE, S.H., ZHANG, J., SIGNORETTI, S., LODA, M., ROBERTS, T.M., "Essential roles of PI(3)K-p110(3 in cell growth, metabolism and tumorigenesis", NATURE, (2008), vol. 454, pages 776 - 779 | Type: | Non-patent literature | Publication information: | - JIA, S., ROBERTS, T.M., ZHAO, J.J., "Should individual P13 kinase isoforms be targeted in cancer?", CURR. OPIN. CELL BIOL., (2009), vol. 21, doi:doi:10.1016/j.ceb.2008.12.007, pages 199 - 208, XP026035452 | DOI: | http://dx.doi.org/10.1016/j.ceb.2008.12.007 | Type: | Non-patent literature | Publication information: | - JIMENEZ, C., JONES, D.R., RODRIGUEZ-VICIANA, P., GONZALEZ-GARCIA, A., LEONARDO, E., WENNSTROM, S., VON KOBBE, C., TORAN, J.L., R.-, "Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase", EMBO J., (1998), vol. 17, pages 743 - 753 | Type: | Non-patent literature | Publication information: | - JUCKER, M., SUDEL, K., HORN, S., SICKEL, M., WEGNER, W., FIEDLER, W., FELDMAN, R.A., "Expression of a mutated form of the p85a regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO", LEUKEMIA, (2002), vol. 16, pages 894 - 901 | Type: | Non-patent literature | Publication information: | - KANG, S., BADER, A.G., VOGT, P.K., "Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic", PROC. NATL. ACAD. SCI. U.S.A., (2005), vol. 102, pages 802 - 807 | Type: | Non-patent literature | Publication information: | - KANG, S., DENLEY, A., VANHAESEBROECK, B., VOGT, P.K., "Oncogenic transformation induced by the p110b, -g, and -d isoforms of class I phosphoinositide 3-kinase", PROC. NATL. ACAD. SCI. U.S.A., (2006), vol. 103, pages 1289 - 1294 | Type: | Non-patent literature | Publication information: | - KATSO, R., OKKENHAUG, K., AHMADI, K., WHITE, S.;, TIMMS, J., WATERFIELD, M.D., "Cellular function of phosphoinositide 3-kinases: implications for development, immunity, homeostasis, and cancer", ANN. REV. CELL. DEV. BIOL., (2001), vol. 17, pages 615 - 675 | Type: | Non-patent literature | Publication information: | - KIM, A.H., KHURSIGARA, G., SUN, X., FRANKE, T.F., CHAO, M.V., "Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1", MOL. CELL. BIOL., (2001), vol. 21, pages 893 - 901 | Type: | Non-patent literature | Publication information: | - KIM, D., DAN, H.C., PARK, S., YANG, L., LIU, Q., KANEKO, S., NING, J., HE, L., YANG, H., SUN, M., "AKT/PKB signaling mechanisms in cancer and chemoresistance", FRONT. BIOSCI., (2005), vol. 10, doi:doi:10.2741/1592, pages 975 - 987, XP009166431 | DOI: | http://dx.doi.org/10.2741/1592 | Type: | Non-patent literature | Publication information: | - KLIPPEL, A., KAVANAUGH, W.M., POT, D., WILLIAMS, L.T., "A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain", MOL. CELL. BIOL., (1997), vol. 17, pages 338 - 344 | Type: | Non-patent literature | Publication information: | - KODAKI, T., WOSCHOLSKI, R., HALLBERG, B., RODRIGUEZ-VICIANA, P., DOWNWARD, J., PARKER, P.J., "The activation of phosphatidylinositol 3-kinase by Ras", CURR. BIOL., (1994), vol. 4, doi:doi:10.1016/S0960-9822(00)00177-9, pages 798 - 806, XP024249253 | DOI: | http://dx.doi.org/10.1016/S0960-9822(00)00177-9 | Type: | Non-patent literature | Publication information: | - KOPS, G.J.P.L., DE RUITER, N.D., DE VRIES-SMITS, A.M.M., POWELL, D.R., BOS, J.L., BURGERING, B.M.T, "Direct control of the Forkhead transcription factor AFX by protein kinase B", NATURE, (1999), vol. 398, doi:doi:10.1038/19328, pages 630 - 634, XP000955388 | DOI: | http://dx.doi.org/10.1038/19328 | Type: | Non-patent literature | Publication information: | - LEE, J.T., JR., STEELMAN, L.S., MCCUBREY, J.A., "Phosphatidylinositol 3'-Kinase Activation Leads to Multidrug Resistance Protein-1 Expression and Subsequent Chemoresistance in Advanced Prostate Cancer Cells", CANCER RES., (2004), vol. 64, pages 8397 - 8404 | Type: | Non-patent literature | Publication information: | - LEE, J.W., SOUNG, Y.H., KIM, S.Y., LEE, H.W., PARK, W.S., NAM, S.W., KIM, S.H., LEE, J.Y., YOO, N.J., LEE, S.H., "PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas", ONCOGENE, (2005), vol. 24, pages 1477 - 1480 | Type: | Non-patent literature | Publication information: | - LEMMON, M.A., "Phosphoinositide recognition domains", TRAFFIC, (2003), vol. 4, pages 201 - 213 | Type: | Non-patent literature | Publication information: | - LEVINE, D.A., BOGOMOLNIY, F., YEE, C.J., LASH, A., BARAKAT, R.R., BORGEN, P.I., BOYD, J., "Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers", CLIN. CANCER RES., (2005), vol. 11, doi:doi:10.1158/1078-0432.CCR-04-2142, pages 2875 - 2878, XP055035718 | DOI: | http://dx.doi.org/10.1158/1078-0432.CCR-04-2142 | Type: | Non-patent literature | Publication information: | - LI, J., YEN, C., LIAW, D., PODSYPANINA, K., BOSE, S., WANG, S.I., PUC, J., MILIARESIS, C., RODGERS, L., MCCOMBIE, R.;, "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer", SCIENCE, (1997), vol. 275, pages 1943 - 1947 | Type: | Non-patent literature | Publication information: | - LI, V.S.W., WONG, C.W., CHAN, T.L., CHAN, A.S.W., ZHAO, W., CHU, K.-M., SO, S., CHEN, X., YUEN, S.T., LEUNG, S.Y., "Mutations of PIK3CA in gastric adenocarcinoma", BMC CANCER, (2005), vol. 5, doi:doi:10.1186/1471-2407-5-29, page 29, XP021004788 | DOI: | http://dx.doi.org/10.1186/1471-2407-5-29 | Type: | Non-patent literature | Publication information: | - LI, Y.-L., TIAN, Z., WU, D.-Y., FU, B.-Y., XIN, Y., "Loss of heterozygosity on 1 Oq23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions", WORLD J. GASTROENTEROL., (2005), vol. 11, pages 285 - 288 | Type: | Non-patent literature | Publication information: | - LIAO, Y., HUNG, M.-C., "Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis", MOL. CELL. BIOL., (2003), vol. 23, pages 6836 - 6848 | Type: | Non-patent literature | Publication information: | - LIU, P., CHENG, H., ROBERTS, T.M., ZHAO, J.J., "Targeting the phosphoinositide 3-kinase pathway in cancer", NAT. REV. DRUG DISC., (2009), vol. 8, doi:doi:10.1038/nrd2926, pages 627 - 644, XP055020926 | DOI: | http://dx.doi.org/10.1038/nrd2926 | Type: | Non-patent literature | Publication information: | - LOPEZ-ILASACA, M., LI, W., UREN, A., YU, J.-C., KAZLAUSKAS, A., GUTKIND, J.S., HEIDARAN, M.A., "Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF", BIOCHEM BIOPHYS. RES. COMMUN., (1997), vol. 232, pages 273 - 277 | Type: | Non-patent literature | Publication information: | - LOPEZ, P.F., SIPPY, B.D., LAMBERT, H.M., THACH, A.B., HINTON, D.R., "Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration- related choroidal neovascular membranes", INVEST. OPHTHALMOL. VIS. SCI., (1996), vol. 37, pages 855 - 868 | Type: | Non-patent literature | Publication information: | - MA, Y.-Y., WEI, S.-J., LIN, Y.-C., LUNG, J.-C., CHANG, T.-C., WHANG-PENG, J., LIU, J.M., YANG, D.-M., YANG, W.K, SHEN, C.-Y., "PIK3CA as an oncogene in cervical cancer", ONCOGENE, (2000), vol. 19, pages 2739 - 2744 | Type: | Non-patent literature | Publication information: | - MAYO, L.D., DIXON, J.E., DURDEN, D.L., TONKS, N.K., DONNER, D.B., "PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy", J. BIOL. CHEM., (2002), vol. 277, pages 5484 - 5489 | Type: | Non-patent literature | Publication information: | - MOMAND, J., WU, H.-H., DASGUPTA, G., "MDM2 - master regulator of the p53 tumor suppressor protein", GENE, (2000), vol. 242, doi:doi:10.1016/S0378-1119(99)00487-4, pages 15 - 29, XP004196500 | DOI: | http://dx.doi.org/10.1016/S0378-1119(99)00487-4 | Type: | Non-patent literature | Publication information: | - MOTTI, M.L., DE MARCO, C., CALIFANO, D., FUSCO, A., VIGLIETTO, G., "Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer", CELL CYCLE, (2004), vol. 3, pages 1074 - 1080 | Type: | Non-patent literature | Publication information: | - MYERS, M.P., PASS, I., BATTY, I.H., VAN DER KAAY, J., STOLAROV, J.P., HEMMINGS, B.A., WIGLER, M.H., DOWNES, C.P., TONKS, N.K., "The lipid phosphatase activity of PTEN is critical for its tumor suppressor function", PROC. NATL. ACAD. SCI. U.S.A., (1998), vol. 95, doi:doi:10.1073/pnas.95.23.13513, pages 13513 - 13518, XP000861905 | DOI: | http://dx.doi.org/10.1073/pnas.95.23.13513 | Type: | Non-patent literature | Publication information: | - NAGATA, Y., LAN, K.-H., ZHOU, X., TAN, M., ESTEVA, F.J., SAHIN, A.A., KLOS, K.S., LI, P., MONIA, B.P., NGUYEN, N.T., "PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients", CANCER CELL, (2004), vol. 6, pages 117 - 127 | Type: | Non-patent literature | Publication information: | - NAITO, A.T., AKAZAWA, H., TAKANO, H., MINAMINO, T., NAGAI, T., ABURATANI, H., KOMURO, I., "Phosphatidylinositol 3-Kinase-Akt Pathway Plays a Critical Role in Early Cardiomyogenesis by Regulating Canonical Wnt Signaling", CIRC. RES., (2005), vol. 97, doi:doi:10.1161/01.RES.0000175241.92285.f8, pages 144 - 151, XP003018975 | DOI: | http://dx.doi.org/10.1161/01.RES.0000175241.92285.f8 | Type: | Non-patent literature | Publication information: | - NEMA, S., WASHKUHN, R.J., BRENDEL, R.J., "Excipients and their use in injectable products", PDA J. PHARM. SCI. TECHNOL., (1997), vol. 51, pages 166 - 171 | Type: | Non-patent literature | Publication information: | - ODA, K., STOKOE, D., TAKETANI, Y., MCCORMICK, F., "High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial Carcinoma", CANCER RES., (2005), vol. 65, doi:doi:10.1158/0008-5472.CAN-05-2620, pages 10669 - 10673, XP055268548 | DOI: | http://dx.doi.org/10.1158/0008-5472.CAN-05-2620 | Type: | Non-patent literature | Publication information: | - OGAWARA, Y., KISHISHITA, S., OBATA, T., ISAZAWA, Y., SUZUKI, T., TANAKA, K., MASUYAMA, N., GOTOH, Y., "Akt enhances Mdm2-mediated ubiquitination and degradation of p53", J. BIOL. CHEM., (2002), vol. 277, pages 21843 - 21850 | Type: | Non-patent literature | Publication information: | - OKI, E., KAKEJI, Y., BABA, H., TOKUNAGA, E., NAKAMURA, T., UEDA, N., FUTATSUGI, M., YAMAMOTO, M., IKEBE, M., MAEHARA, Y., "Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer", J. GASTROENTEROL. HEPATOL., (2006), vol. 21, pages 814 - 818 | Type: | Non-patent literature | Publication information: | - OLSON, J.M., HALLAHAN, A.R., "p38 MAP kinase: a convergence point in cancer therapy", TRENDS MOL. MED., (2004), vol. 10, pages 125 - 129 | Type: | Non-patent literature | Publication information: | - OSAKI, M., OSHIMURA, M., ITO, H., "PI3K-Akt pathway: Its functions and alterations in human cancer", APOPTOSIS, (2004), vol. 9, doi:doi:10.1023/B:APPT.0000045801.15585.dd, pages 667 - 676, XP019204869 | DOI: | http://dx.doi.org/10.1023/B:APPT.0000045801.15585.dd | Type: | Non-patent literature | Publication information: | - PASTORINO, J.G., TAFANI, M., FARBER, J.L., "Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway", J. BIOL. CHEM., (1999), vol. 274, pages 19411 - 19416 | Type: | Non-patent literature | Publication information: | - PENDARIES, C., TRONCHERE, H., PLANTAVID, M., PAYRASTRE, B., "Phosphoinositide signaling disorders in human diseases", FEBS LETT., (2003), vol. 546, doi:doi:10.1016/S0014-5793(03)00437-X, pages 25 - 31, XP004433615 | DOI: | http://dx.doi.org/10.1016/S0014-5793(03)00437-X | Type: | Non-patent literature | Publication information: | - PHILLIPS, W.A., ST. CLAIR, F., MUNDAY, A.D., THOMAS, R.J.S., MITCHELL, C.A., "Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors", CANCER, (1998), vol. 83, pages 41 - 47 | Type: | Non-patent literature | Publication information: | - PHILP, A.J., CAMPBELL, I.G., LEET, C., VINCAN, E., ROCKMAN, S.P., WHITEHEAD, R.H., THOMAS, R.J.S., PHILLIPS, W.A., "The phosphatidylinositol 3'-kinase p85a gene is an oncogene in human ovarian and colon tumors", CANCER RES., (2001), vol. 61, pages 7426 - 7429, XP002505603 | Type: | Non-patent literature | Publication information: | - POWELL, M.F., NGUYEN, T., BALOIAN, L., "Compendium of excipients for parenteral formulations", PDA J. PHARM. SCI. TECHNOL., (1998), vol. 52, pages 238 - 311, XP009119027 | Type: | Non-patent literature | Publication information: | - POWIS, G., BONJOUKLIAN, R., BERGGREN, M.M., GALLEGOS, A., ABRAHAM, R., ASHENDEL, C., ZALKOW, L., MATTER, W.F., DODGE, J., "Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase", CANCER RES., (1994), vol. 54, pages 2419 - 2423 | Type: | Non-patent literature | Publication information: | - PU, P., KANG, C., ZHANG, Z., LIU, X., JIANG, H., "Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo", TECHNOL. CANCER RES. TREAT., (2006), vol. 5, pages 271 - 280, XP008092957 | Type: | Non-patent literature | Publication information: | - RAHIMI, N., TREMBLAY, E., ELLIOTT, B., "Phosphatidylinositol 3-kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells", J. BIOL. CHEM., (1996), vol. 271, pages 24850 - 24855 | Type: | Non-patent literature | Publication information: | - ROCHE, S., DOWNWARD, J., RAYNAL, P., COURTNEIDGE, S.A., "A function for phosphatidylinositol 3-kinase b (p85a-p110b) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction", MOL. CELL. BIOL., (1998), vol. 18, pages 7119 - 7129 | Type: | Non-patent literature | Publication information: | - ROCHE, S., KOEGL, M., COURTNEIDGE, S.A., "The phosphatidylinositol 3-kinase a is required for DNA synthesis induced by some, but not all, growth factors", PROC. NATL. ACAD. SCI. U.S.A., (1994), vol. 91, pages 9185 - 9189 | Type: | Non-patent literature | Publication information: | - ROMASHKOVA, J.A., MAKAROV, S.S., "Nf-kB is a target of Akt in anti- apoptotic PDGF signalling", NATURE, (1999), vol. 401, pages 86 - 90 | Type: | Non-patent literature | Publication information: | - SAAL, L.H., HOLM, K., MAURER, M., MEMEO, L., SU, T., WANG, X., YU, J.S., MALMSTROEM, P.-O., MANSUKHANI, M., ENOKSSON, J., "PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma", CANCER RES., (2005), vol. 65, doi:doi:10.1158/0008-5472-CAN-04-3913, pages 2554 - 2559, XP055070087 | DOI: | http://dx.doi.org/10.1158/0008-5472-CAN-04-3913 | Type: | Non-patent literature | Publication information: | - SAMUELS, Y., DIAZ, L.A., JR., SCHMIDT-KITTLER, 0., CUMMINS, J.M., DELONG, L., CHEONG, I., RAGO, C., HUSO, D.L., LENGAUER, C., KINZ, "Mutant PIK3CA promotes cell growth and invasion of human cancer cells", CANCER CELL, (2005), vol. 7, doi:doi:10.1016/J.CCR.2005.05.014, pages 561 - 573, XP002729908 | DOI: | http://dx.doi.org/10.1016/J.CCR.2005.05.014 | Type: | Non-patent literature | Publication information: | - SAMUELS, Y., ERICSON, K., "Oncogenic P13K and its role in cancer", CURR. OPIN. ONCOL., (2006), vol. 18, doi:doi:10.1097/01.cco.0000198021.99347.b9, pages 77 - 82, XP009172157 | DOI: | http://dx.doi.org/10.1097/01.cco.0000198021.99347.b9 | Type: | Non-patent literature | Publication information: | - SAMUELS, Y., WANG, Z., BARDELLI, A., SILLIMAN, N., PTAK, J., SZABO, S., YAN, H., GAZDAR, A., POWELL, S.M., RIGGINS, G.J., "Brevia: High frequency of mutations of the PIK3Ca gene in human cancers", SCIENCE, (2004), vol. 304, page 554 | Type: | Non-patent literature | Publication information: | - SCHEID, M.P., MARIGNANI, P.A., WOODGETT, J.R., "Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B", MOL. CELL. BIOL., (2002), vol. 22, pages 6247 - 6260 | Type: | Non-patent literature | Publication information: | - SCHULTZ, R.M., MERRIMAN, R.L., ANDIS, S.L., BONJOUKLIAN, R., GRINDEY, G.B., RUTHERFORD, P.G., GALLEGOS, A., MASSEY, K., POWIS, G., "In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin", ANTICANCER RES., (1995), vol. 15, pages 1135 - 1139, XP009116931 | Type: | Non-patent literature | Publication information: | - SEGRELLES, C., MORAL, M., LARA, M.F., RUIZ, S., SANTOS, M., LEIS, H., GARCIA-ESCUDERO, R., MARTINEZ-CRUZ, A.B., MARTINEZ-PALACIO,, "Molecular determinants of Akt-induced keratinocyte transformation", ONCOGENE, (2006), vol. 25, pages 1174 - 1185 | Type: | Non-patent literature | Publication information: | - SEKIMOTO, T., FUKUMOTO, M., YONEDA, Y., "14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27Kip1", EMBO J., (2004), vol. 23, pages 1934 - 1942 | Type: | Non-patent literature | Publication information: | - SEMBA, S., ITOH, N., ITO, M., YOUSSEF, E.M., HARADA, M., MORIYA, T., KIMURA, W., YAMAKAWA, M., "Down-regulation of PIK3CG catalytic subunit of phosphatidylinositol 3-OH kinase by CpG hypermethylation in human colorectal carcinoma", CLIN. CANCER RES., (2002), vol. 8, pages 3824 - 3831, XP055231234 | Type: | Non-patent literature | Publication information: | - SHAYESTEH, L., LU, Y., KUO, W.-L., BALDOCCHI, R., GODFREY, T., COLLINS, C., PINKEL, D., POWELL, B., MILLS, G.B., GRAY, J.W., "PIK3CA is implicated as an oncogene in ovarian cancer", NAT. GENET., (1999), vol. 21, doi:doi:10.1038/5042, pages 99 - 102, XP002539225 | DOI: | http://dx.doi.org/10.1038/5042 | Type: | Non-patent literature | Publication information: | - SHEKAR, S.C., WU, H., FU, Z., YIP, S.-C., NAGAJYOTHI;, CAHILL, S.M., GIRVIN, M.E., BACKER, J.M., "Mechanism of Constitutive Phosphoinositide 3-Kinase Activation by Oncogenic Mutants of the p85 Regulatory Subunit", J. BIOL. CHEM., (2005), vol. 280, pages 27850 - 27855 | Type: | Non-patent literature | Publication information: | - SILVESTRINI, R., ZAFFARONI, N., ORLANDI, L., ORIANA, S., "In vitro cytotoxic activity of taxol and taxotere on primary cultures and established cell lines of human ovarian cancer", STEM CELLS, (1993), vol. 11, pages 528 - 535 | Type: | Non-patent literature | Publication information: | - STAHL, J.M., CHEUNG, M., SHARMA, A., TRIVEDI, N.R., SHANMUGAM, S., ROBERTSON, G.P., "Loss of PTEN Promotes Tumor Development in Malignant Melanoma", CANCER RES., (2003), vol. 63, pages 2881 - 2890, XP002590380 | Type: | Non-patent literature | Publication information: | - STAMBOLIC, V., SUZUKI, A., DE LA POMPA, J.L., BROTHERS, G.M., MIRTSOS, C., SASAKI, T., RULAND, J., PENNINGER, J.M., SIDEROVSKI, D., "Negative regulation of PKB/Akt-Dependent cell survival by the tumor suppressor PTEN", CELL, (1998), vol. 95, doi:doi:10.1016/S0092-8674(00)81780-8, pages 29 - 39, XP002984475 | DOI: | http://dx.doi.org/10.1016/S0092-8674(00)81780-8 | Type: | Non-patent literature | Publication information: | - STAUFFER, F., HOLZER, P., GARCIA-ECHEVERRIA, C., "Blocking the PI3K/PKB pathway in tumor cells", CURR. MED. CHEM.: ANTI-CANCERAGENTS, (2005), vol. 5, doi:doi:10.2174/1568011054866937, pages 449 - 462, XP009112438 | DOI: | http://dx.doi.org/10.2174/1568011054866937 | Type: | Non-patent literature | Publication information: | - STECK, P.A., PERSHOUSE, M.A., JASSER, S.A., YUNG, W.K.A., LIN, H., LIGON, A.H., LANGFORD, L.A., BAUMGARD, M.L., HATTIER, T., DAVIS, "Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers", NAT. GENET., (1997), vol. 15, pages 356 - 362 | Type: | Non-patent literature | Publication information: | - STEPHENS, L., WILLIAMS, R., HAWKINS, P., "Phosphoinositide 3-kinases as drug targets in cancer", CURR. OPIN. PHARMACOL., (2005), vol. 5, doi:doi:10.1016/j.coph.2005.03.002, pages 357 - 365, XP004969001 | DOI: | http://dx.doi.org/10.1016/j.coph.2005.03.002 | Type: | Non-patent literature | Publication information: | - STILL, W.C., KAHN, M., MITRA, A., "Rapid chromatographic technique for preparative separations with moderate resolution", J. ORG. CHEM., (1978), vol. 43, doi:doi:10.1021/jo00408a041, pages 2923 - 2925, XP000882390 | DOI: | http://dx.doi.org/10.1021/jo00408a041 | Type: | Non-patent literature | Publication information: | - STRICKLEY, R.G., "Parenteral formulations of small molecules therapeutics marketed in the United States (1999). Part I", PDA J. PHARM. SCI. TECHNOL., (1999), vol. 53, pages 324 - 349 | Type: | Non-patent literature | Publication information: | - SU, J.D., MAYO, L.D., DONNER, D.B., DURDEN, D.L., "PTEN and Phosphatidylinositol 3'-Kinase Inhibitors Up-Regulate p53 and Block Tumor-induced Angiogenesis: Evidence for an Effect on the Tumor and Endothelial Compartment", CANCER RES., (2003), vol. 63, pages 3585 - 3592, XP008083881 | Type: | Non-patent literature | Publication information: | - TANAKA, M., GROSSMAN, H.B., "In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin", GENE THERAP., (2003), vol. 10, pages 1636 - 1642 | Type: | Non-patent literature | Publication information: | - TANG, E.D., NUNEZ, G., BARR, F.G., GUAN, K.-L., "Negative regulation of the forkhead transcription factor FKHR by Akt", J. BIOL. CHEM., (1999), vol. 274, doi:doi:10.1074/jbc.274.24.16741, pages 16741 - 16746, XP002983897 | DOI: | http://dx.doi.org/10.1074/jbc.274.24.16741 | Type: | Non-patent literature | Publication information: | - TAYLOR, V., WONG, M., BRANDTS, C., REILLY, L., DEAN, N.M., COWSERT, L.M., MOODIE, S., STOKOE, D., "5' Phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells", MOL. CELL. BIOL., (2000), vol. 20, pages 6860 - 6871 | Type: | Non-patent literature | Publication information: | - TOKER, A., "Phosphoinositides and signal transduction", CELL MOL. LIFE SCI., (2002), vol. 59, pages 761 - 779 | Type: | Non-patent literature | Publication information: | - TRAER, C.J., FOSTER, F.M., ABRAHAM, S.M., FRY, M.J., "Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?", BULL. CANCER (PARIS, (2006), vol. 93, pages E53 - 58, XP002697164 | Type: | Non-patent literature | Publication information: | - VANHAESEBROECK, B., LEEVERS, S.J., AHMADI, K., TIMMS, J., KATSO, R., DRISCOLL, P.C., WOSCHOLSKI, R., PARKER, P.J., WATERFIELD, M.D, "Synthesis and function of 3-phosphorylated inositol lipids", ANN. REV. BIOCHEM., (2001), vol. 70, pages 535 - 602 | Type: | Non-patent literature | Publication information: | - VANHAESEBROECK, B., WATERFIELD, M.D., "Signaling by Distinct Classes of Phosphoinositide 3-Kinases", EXP. CELL RES., (1999), vol. 253, pages 239 - 254 | Type: | Non-patent literature | Publication information: | - VIVANCO, I., SAWYERS, C.L., "The phosphatidylinositol 3- Kinase-AKT pathway in human cancer", NAT. REV. CANCER, (2002), vol. 2, doi:doi:10.1038/nrc839, pages 489 - 501, XP009035869 | DOI: | http://dx.doi.org/10.1038/nrc839 | Type: | Non-patent literature | Publication information: | - VOGT, P.K., GYMNOPOULOS, M., HART, J.R., "PI 3-kinase and cancer: changing accents", CURR. OPIN. GENET. DEV., (2009), vol. 19, doi:doi:10.1016/j.gde.2008.11.011, pages 12 - 17, XP025994212 | DOI: | http://dx.doi.org/10.1016/j.gde.2008.11.011 | Type: | Non-patent literature | Publication information: | - WANG, Y., HELLAND, A., HOLM, R., KRISTENSEN GUNNAR, B., BORRESEN-DALE, A.-L., "PIK3CA mutations in advanced ovarian carcinomas", HUMAN MUTATION, (2005), vol. 25, page 322 | Type: | Non-patent literature | Publication information: | - WEE, S., LENGAUER, C., WIEDERSCHAIN, D., "Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development", CURR. OPIN. ONCOL., (2008), vol. 20, doi:doi:10.1097/CCO.0b013e3282f3111e, pages 77 - 82, XP009172155 | DOI: | http://dx.doi.org/10.1097/CCO.0b013e3282f3111e | Type: | Non-patent literature | Publication information: | - WEST, K.A., CASTILLO, S.S., DENNIS, P.A., "Activation of the PI3K/Akt pathway and chemotherapeutic resistance", DRUG RESIST. UPDATES, (2002), vol. 5, doi:doi:10.1016/S1368-7646(02)00120-6, pages 234 - 248, XP002964818 | DOI: | http://dx.doi.org/10.1016/S1368-7646(02)00120-6 | Type: | Non-patent literature | Publication information: | - WHYTE, D.B., HOLBECK, S.L., "Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines", BIOCHEM BIOPHYS. RES. COMMUN., (2006), vol. 340, pages 469 - 475 | Type: | Non-patent literature | Publication information: | - WILKER, E., LU, J., RHO, 0., CARBAJAL, S., BELTRAN, L., DIGIOVANNI, J., "Role of P13K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion", MOL. CARCINOG., (2005), vol. 44, doi:doi:10.1002/mc.20132, pages 137 - 145, XP055231296 | DOI: | http://dx.doi.org/10.1002/mc.20132 | Type: | Non-patent literature | Publication information: | - WORKMAN, P., "Inhibiting the phosphoinositide 3- kinase pathway for cancer treatment", BIOCHEM. SOC. TRANS., (2004), vol. 32, pages 393 - 396 | Type: | Non-patent literature | Publication information: | - WU, G., XING, M., MAMBO, E., HUANG, X., LIU, J., GUO, Z., CHATTERJEE, A., GOLDENBERG, D., GOLLIN, S.M., SUKUMAR, S., "Somatic mutation and gain of copy number of PIK3CA in human breast cancer", BREAST CANCER RES., (2005), vol. 7, doi:doi:10.1186/bcr1262, pages R609 - R616, XP021011863 | DOI: | http://dx.doi.org/10.1186/bcr1262 | Type: | Non-patent literature | Publication information: | - YAP, D.B., HSIEH, J.K., LU, X., "Mdm2 inhibits the apoptotic function of p53 mainly by targeting it for degradation", J. BIOL. CHEM., (2000), vol. 275, pages 37296 - 37302 | Type: | Non-patent literature | Publication information: | - YUAN, T.L., CANTLEY, L.C., "P13K pathway alterations in cancer: variations on a theme", ONCOGENE, (2008), vol. 27, doi:doi:10.1038/onc.2008.245, pages 5497 - 5510, XP055082753 | DOI: | http://dx.doi.org/10.1038/onc.2008.245 | Type: | Non-patent literature | Publication information: | - YUAN, Z.-Q., FELDMAN, R.I., SUSSMAN, G.E., COPPOLA, D., NICOSIA, S.V., CHENG, J.Q., "AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1: Implication of AKT2 in Chemoresistance", J. BIOL. CHEM., (2003), vol. 278, pages 23432 - 23440 | Type: | Non-patent literature | Publication information: | - ZHAO, H., DUPONT, J., YAKAR, S., KARAS, M., LEROITH, D., "PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells", ONCOGENE, (2004), vol. 23, doi:doi:10.1038/sj.onc.1207162, pages 786 - 794, XP008083876 | DOI: | http://dx.doi.org/10.1038/sj.onc.1207162 | Type: | Non-patent literature | Publication information: | - ZHAO, J.J., CHENG, H., JIA, S.;, WANG, L., GJOERUP, O.V., MIKAMI, A., ROBERTS, T.M., "The p110a isoform of P13K is essential for proper growth factor signaling and oncogenic transformation", PROC. NATL. ACAD. SCI. U.S.A., (2006), vol. 103, doi:doi:10.1073/pnas.0607899103, pages 16296 - 16300, XP002462087 | DOI: | http://dx.doi.org/10.1073/pnas.0607899103 | Type: | Non-patent literature | Publication information: | - ZHICHKIN, P., FAIRFAX, D.J., EISENBEIS, S.A., "A general procedure for the synthesis of 2-substituted pyrimidine-5-carboxylic esters", SYNTHESIS, (2002), pages 720 - 722 | Type: | Non-patent literature | Publication information: | - ZHOU, B.P., LIAO, Y., XIA, W., SPOHN, B., LEE, M.H., HUNG, M.C., "Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu- overexpressing cells", NAT. CELL BIOL., (2001), vol. 3, pages 245 - 252 |